igalik
molecul
identifi
lizard
deza
et
al
yet
iga
remain
inadequ
understood
least
respect
biolog
function
part
reflect
molecular
heterogen
well
occurr
two
distinct
physiolog
compart
system
circul
mucos
secret
detail
chapter
volum
iga
human
anthropoid
ape
occur
two
subclass
well
monomer
polymer
dimer
higher
secretori
form
secretori
iga
siga
predomin
mucos
secret
activ
protect
surfac
colon
invas
pathogen
injuri
toxin
rel
well
understood
howev
function
circul
serum
iga
remain
poorli
understood
despit
metabol
cost
involv
synthes
iga
impli
signific
physiolog
benefit
deriv
produc
iga
also
readili
dispens
isotyp
reveal
iga
defici
common
form
primari
immunodefici
occur
individu
caucasian
origin
although
less
frequent
popul
yet
affect
individu
usual
sever
immunocomprom
chapter
consider
fact
reveal
much
iga
remain
perplex
nevertheless
specif
iga
antibodi
particularli
mucos
secret
document
provid
signific
protect
varieti
toxin
virus
bacteria
protozoa
human
experiment
anim
model
tabl
review
russel
kilian
see
chapter
convent
concept
siga
neutral
toxin
enzym
inhibit
adher
microorgan
mucos
surfac
facilit
clearanc
mucu
layer
remain
essenti
valid
siga
well
adapt
mucos
protect
abund
carbohydr
chain
render
hydrophil
neg
charg
addit
secretori
compon
sc
siga
shown
protect
proteolysi
crottet
therebi
prolong
surviv
within
enzymat
hostil
environ
intestin
tract
consist
model
show
sc
fold
around
juxtapos
fc
domain
two
iga
monom
held
togeth
partli
jchain
polypeptid
royl
et
al
base
computer
predict
deriv
ig
structur
solut
studi
chapter
howev
crystallograph
model
siga
even
fc
jsc
segment
yet
avail
confirm
consid
biolog
function
iga
one
keep
mind
iga
heterogen
immunoglobulin
occur
sever
molecular
form
subclass
allotyp
probabl
glycoform
although
fernandez
et
al
polar
mous
epitheli
cell
latter
littl
explor
pattern
heterogen
also
differ
speci
impli
function
might
differ
subtl
way
also
notabl
human
along
close
rel
great
ape
evolv
novel
subclass
extend
prolinerich
oglycosyl
hing
region
chapter
circul
human
blood
plasma
rel
high
concentr
predominantli
monomer
form
contrast
eutherian
mammal
investig
possess
one
iga
isotyp
structur
akin
predominantli
dimer
circul
concentr
around
mgml
similar
concentr
human
quit
physiolog
signific
differ
human
mammal
repres
uncertain
implic
extra
abund
monomer
fulfil
addit
function
remain
larg
unknown
steadyst
concentr
ig
plasma
howev
give
mislead
impress
take
account
halfliv
differ
isotyp
wherea
igg
averag
circul
halflif
day
day
day
morel
et
al
author
estim
synthet
rate
plasma
mg
kgday
mgkgday
wherea
igg
mgkg
day
given
igg
consist
four
subclass
therefor
probabl
abundantli
produc
circul
ig
isotyp
human
antibodi
specif
protein
polysaccharid
report
differ
distribut
subclass
antibodi
carbohydr
often
preferenti
express
howev
distinct
absolut
mestecki
russel
otherwis
clear
function
differ
emerg
isotyp
bind
sc
repres
siga
bind
iga
fc
receptor
myeloid
cell
equal
major
differ
suscept
cleavag
bacteri
proteas
see
sect
enzym
therebi
disrupt
structur
function
advantag
possess
difficult
grasp
seem
like
pathogen
exploit
weak
human
heterogen
aris
exist
least
two
possibl
three
allotyp
human
appear
repres
constant
region
domainswap
variant
chintalacharuvu
et
al
differ
glycoform
aris
differenti
occurr
nglycosyl
site
subclass
allotyp
well
presenc
olink
glycan
hing
region
mattu
et
al
addit
structur
analysi
nlink
glycan
myeloma
protein
reveal
consider
sequenc
variat
might
also
occur
normal
iga
endo
et
al
glycan
interact
lectinlik
receptor
modul
interact
fc
receptor
complement
compon
like
subtl
variat
glycosyl
affect
function
properti
iga
way
yet
examin
detail
particular
exampl
howev
defect
glycosyl
might
respons
iga
nephropathi
chapter
mammal
also
possess
multipl
iga
subclass
lagomorph
rabbit
alli
gene
iga
subclass
express
although
equal
physiolog
signific
remain
mysteri
knight
rhee
limit
genet
data
also
suggest
presenc
multipl
iga
subclass
monotrem
marsupi
peppard
et
al
although
human
polymer
p
iga
constitut
total
plasma
iga
sever
studi
shown
initi
serum
iga
compon
system
immun
respons
piga
follow
miga
review
russel
et
al
discuss
section
piga
better
abl
crosslink
receptor
phagocyt
might
therefor
advantag
protect
infect
otherwis
function
signific
matur
respons
toward
miga
uncertain
studi
reveal
individu
igasecret
cell
first
produc
piga
later
miga
moldoveanu
et
al
longterm
product
circul
iga
probabl
due
plasma
cell
bone
marrow
mainli
secret
hijman
becom
clear
colon
microorgan
whether
pathogen
commens
must
adher
host
tissu
surfac
also
recogn
import
function
antibodymedi
defens
mucosa
inhibit
microbi
adher
readili
envisag
isotyp
antibodi
specif
microbi
adher
epitop
would
inhibit
interact
host
receptor
howev
siga
particularli
well
suit
role
extens
glycosyl
account
weight
confer
hydrophil
neg
charg
molecul
sc
contain
carbohydr
contribut
much
properti
siga
macromolecular
bulk
siga
kda
dimer
form
might
also
import
compar
studi
igg
serum
miga
piga
siga
antibodi
specif
antigen
reveal
superior
latter
inhibit
adher
differ
organ
host
surfac
hajisheng
et
al
phalipon
et
al
see
chapter
even
siga
antibodi
specif
adhesin
antigen
epitop
cover
surfac
microb
hydrophil
shell
might
abl
repel
attach
microb
surfac
agglutin
microb
facilit
multipl
valenc
case
dimer
siga
might
promot
remov
mucu
stream
carbohydr
residu
siga
might
also
enabl
inhibit
adher
microorgan
independ
antibodi
activ
bind
carbohydratespecif
adhesin
bacteria
exampl
certain
strain
escherichia
coli
possess
mannosespecif
type
pili
agglutin
especi
carri
mannoserich
glycan
result
inhibit
adher
epitheli
cell
wold
et
al
case
might
necessari
sialic
acid
termin
residu
remov
expos
interact
sugar
residu
royl
et
al
howev
extent
interact
function
vivo
inhibit
adher
convers
promot
depend
size
aggreg
form
debat
friman
et
al
liljemark
et
al
interest
controversi
exampl
repres
streptococcu
pneumonia
propos
exploit
abil
bind
sc
enhanc
epitheli
cell
invas
induc
retrograd
reuptak
sc
brock
et
al
zhang
et
al
old
concept
biolog
function
siga
mucos
surfac
siga
array
surfac
mucu
layer
form
kind
immunolog
flypap
allow
entrap
microb
swept
along
mucu
flow
appeal
idea
might
support
experiment
evid
tent
interact
siga
mucin
possibl
involv
mucinlik
hing
region
even
format
disulfid
bond
propos
clamp
recent
studi
indic
siga
diffus
freeli
mucu
saltzman
et
al
coat
microorgan
siga
antibodi
reduc
hydrophob
facilit
entrap
mucu
edebo
et
al
magnusson
phalipon
et
al
siga
associ
highmolecularweight
fraction
saliva
also
contain
mucin
bind
siga
mucin
describ
biesbrock
et
al
interestingli
spermatozoa
coat
siga
abil
penetr
cervic
mucu
impair
treatment
proteas
remov
fc
sc
region
restor
abil
bronson
et
al
like
crosslink
complex
form
polyval
siga
interfer
sperm
mobil
allevi
proteas
cleav
monoval
fab
fragment
numer
exampl
enzym
toxin
neutral
siga
antibodi
describ
includ
cholera
enterotoxin
johnson
et
al
lyck
et
al
stubb
et
al
bacteri
neuraminidas
hyaluronidas
chondroitin
sulfatas
fukui
et
al
glycosyltransferas
streptococcu
mutan
streptococcu
sobrinu
involv
dental
cari
develop
smith
et
al
bacteri
proteas
reinholdt
kilian
instanc
demonstr
piga
antibodi
dival
f
ab
fragment
iga
effect
equival
miga
igg
antibodi
johnson
et
al
norrbyteglund
et
al
impli
neutral
involv
simpli
blockad
substrat
bind
induct
conform
chang
affect
enzym
toxic
activ
would
independ
isotyp
presenc
fc
region
molecular
conform
contrast
monoval
fab
fragment
antibodi
bacteri
proteas
retain
inhibitori
activ
gilbert
et
al
secretori
iga
antibodi
well
document
neutral
wide
varieti
virus
although
mani
instanc
might
due
inhibit
bind
uptak
viru
cell
receptor
viral
replic
inhibit
variou
way
includ
inhibit
viral
uncoat
intracellular
replic
process
depend
epitop
specif
isotyp
concentr
antibodi
viru
cell
involv
armstrong
dimmock
castilla
et
al
liew
et
al
piga
siga
antibodi
might
effect
migafor
exampl
inhibit
hemagglutin
influenza
viru
renegar
et
al
howev
piga
antibodi
neutral
infect
epsteinbarr
viru
ebv
bcell
via
complement
receptor
promot
infect
colon
carcinoma
cell
via
pigr
least
unpolar
cell
vitro
sixbey
yao
hand
polar
epitheli
cell
transport
pigacomplex
ebv
basal
apic
surfac
without
becom
infect
viru
vitro
vivo
gan
et
al
likewis
iga
antibodi
might
neutral
human
immunodefici
viru
hiv
infect
tcell
burnett
et
al
wherea
iga
antibodi
enhanc
hiv
infect
monocyt
kozlowski
et
al
siga
plasma
iga
uninfect
individu
especi
effect
inhibit
uptak
transcytosi
epitheli
cell
devito
et
al
siga
antibodi
eldkwa
epitop
shown
prevent
epitheli
cell
uptak
alfsen
et
al
matoba
et
al
piga
antibodi
reexport
viru
apic
surfac
pigrexpress
epitheli
cell
bomsel
et
al
process
resembl
remov
absorb
antigen
kaetzel
et
al
see
chapter
furthermor
possibl
virus
neutral
within
epitheli
cell
piga
antibodi
pigrmedi
transcytosi
mazanec
et
al
occur
vesicl
contain
replic
viru
must
interact
vesicl
carri
piga
across
epitheli
cell
evid
obtain
vitro
vivo
feng
et
al
huang
et
al
mazanec
et
al
ruggeri
et
al
yan
et
al
see
chapter
similar
way
abil
shigella
lipopolysaccharid
lp
activ
nuclear
factor
within
epitheli
cell
inhibit
piga
antibodi
pigrmedi
transcellular
transport
fernandez
et
al
extent
mechan
oper
natur
condit
depend
presenc
iga
antibodysecret
cell
appropri
specif
lamina
propria
adjac
site
viral
invas
lp
uptak
moreov
piga
transport
larg
cell
intestin
crypt
might
encount
virus
lp
enter
mcell
villi
uptak
food
antigen
intestin
inhibit
siga
antibodi
previous
develop
respons
walker
et
al
propos
mechan
exploit
inhibit
absorpt
environment
toxin
carcinogen
silbart
keren
likewis
absorpt
antigen
airway
inhibit
simultan
administr
iga
antibodi
stoke
et
al
igadefici
subject
show
increas
absorpt
food
antigen
format
circul
immun
complex
cunninghamrundl
et
al
might
predispos
greater
environment
antigen
challeng
well
increas
suscept
atop
allergi
autoimmun
diseas
stoke
et
al
howev
recent
studi
shown
allerg
patient
increas
level
allergenspecif
ige
antibodi
also
iga
includ
siga
igg
antibodi
normal
detect
healthi
individu
benson
et
al
peebl
et
al
reed
et
al
propos
cleavag
potenti
protect
antibodi
bacteri
proteas
might
contribut
find
mechan
respons
immun
exclus
siga
probabl
similar
describ
earlier
includ
hydrophil
agglutin
mucu
entrap
also
possibl
pigrmedi
transport
piga
enterocyt
serv
reexport
absorb
antigen
becom
complex
piga
antibodi
lamina
propria
see
chapter
similar
process
describ
hepatobiliari
transport
elimin
antigen
complex
piga
antibodi
see
sect
contrast
propos
siga
antibodi
facilit
uptak
reoviru
mcell
peyer
patch
therebi
enhanc
mucos
immun
respons
weltzin
et
al
see
chapter
howev
difficult
reconcil
anoth
report
describ
inhibit
reoviru
infect
mcell
siga
antibodi
silvey
et
al
lectinlik
iga
receptor
murin
mcell
distinct
pigr
asialoglycoprotein
receptor
might
respons
select
bind
human
describ
manti
et
al
mucos
secret
contain
numer
innat
defens
factor
highli
effect
kill
inhibit
broad
rang
microorgan
offer
ampl
opportun
synerg
siga
antibodi
although
specul
siga
antibodi
might
target
factor
specif
microb
scant
molecular
evid
interact
classic
exampl
siga
antibodi
interact
complement
lysozym
lyse
e
coli
adinolfi
et
al
unfortun
prove
difficult
reproduc
thought
undetect
contamin
respons
observ
effect
bacteriostat
synergi
lactoferrin
siga
antibodi
stephen
et
al
funakoshi
et
al
possibl
due
antibodymedi
inhibit
altern
mechan
iron
acquisit
coval
complex
lactoferrin
siga
report
watanab
et
al
myeloma
protein
enhanc
abil
lactoperoxidaseh
scn
inhibit
mutan
metabol
attribut
stabil
enzym
activ
tenovuo
et
al
interact
siga
human
secretori
leukocyt
proteas
inhibitor
postul
role
intrauterin
defens
hirano
et
al
question
whether
iga
activ
complement
gener
controversi
review
russel
kilian
accept
iga
activ
classic
complement
pathway
ccp
iga
molecul
contain
motif
statement
commonli
found
mani
text
iga
activ
altern
complement
pathway
acp
howev
examin
refer
primari
literatur
care
consider
condit
experi
perform
numer
report
describ
activ
acp
heataggreg
chemic
crosslink
denatur
human
serum
iga
colostr
siga
myeloma
protein
artifici
recombin
iga
antibodi
construct
produc
transfect
cell
line
complex
hapten
antigen
boackl
et
al
hiemstra
et
al
valim
lachmann
contrast
human
monoclon
polyclon
iga
antibodi
physiolog
complex
antigen
activ
acp
colten
bienenstock
imai
et
al
et
al
russel
mansa
howev
iga
antibodi
might
activ
acp
bound
hydrophob
surfac
chemic
crosslink
deglycosyl
nikolova
et
al
russel
mansa
zhang
lachmann
interestingli
acp
activ
aggreg
iga
depend
fc
fcsc
region
instead
fab
respons
acp
activ
igg
nikolova
et
al
heataggreg
mixtur
human
igg
iga
fixat
acp
depend
proport
igg
becom
coval
coupl
igg
compon
waldo
cochran
mous
rat
rabbit
iga
antihapten
antibodi
complex
hapten
protein
activ
acp
pfaffenbach
et
al
rit
et
al
schneiderman
et
al
howev
comparison
mous
monoclon
antibodi
differ
isotyp
studi
complementmedi
solubil
immun
complex
show
wherea
igm
igg
complex
fix
iga
complex
stewart
et
al
sever
factor
might
contribut
conflict
result
iga
purifi
procedur
involv
exposur
denatur
condit
might
conform
alter
recombin
iga
protein
produc
hybridoma
transfectoma
cell
often
abnorm
incomplet
glycosyl
moreov
heavili
hapten
protein
activ
acp
nevertheless
remain
possibl
differ
amino
acid
sequenc
well
glycosyl
human
anim
iga
result
subtl
import
function
differ
includ
abil
activ
acp
numer
studi
shown
iga
antibodi
effect
interfer
complement
activ
mediat
antibodi
isotyp
exacerb
meningococc
infect
patient
attribut
presenc
iga
antibodi
capsular
polysaccharid
inhibit
igg
igm
antibodydepend
complementmedi
lysi
neisseria
meningitidi
griffiss
et
al
similar
find
made
bacteriolysi
brucella
abortu
hall
et
al
immun
hemolysi
erythrocyt
arthu
reaction
russelljon
et
al
human
monoclon
polyclon
antibodi
inhibit
igg
antibodydepend
ccp
activ
vitro
nikolova
et
al
interestingli
proteasegener
fragment
iga
antibodi
also
inhibit
iggand
complementmedi
process
jarvi
griffiss
howev
lysi
n
meningitidi
iga
antibodi
outer
membran
protein
contrast
antibodi
capsular
polysaccharid
mechan
requir
remain
unexplain
jarvi
griffiss
jarvi
li
definit
evid
provid
experi
use
recombin
human
monoclon
antibodi
meningococc
porin
wherea
igg
antibodi
mediat
complementdepend
bacteriolysi
iga
ident
antigenbind
domain
fail
also
block
iggdepend
bacteriolysi
vidarsson
et
al
third
pathway
complement
activ
describ
involv
lectin
mannosebind
lectin
mbl
structur
resembl
bind
termin
mannos
fucos
nacetylglucosamin
residu
presenc
calcium
mblassoci
serin
proteas
homolog
similarli
cleav
remaind
classic
pathway
follow
et
al
piga
miga
bind
mbl
initi
pathway
roo
et
al
although
full
physiolog
signific
lectin
pathway
yet
elucid
might
explain
controversi
surround
complement
activ
iga
gener
conclud
nativ
human
iga
antibodi
complex
antigen
littl
abil
activ
complement
either
ccp
acp
within
mucosa
iga
abund
abil
resist
complement
activ
consequ
inflammatori
reaction
might
help
maintain
integr
mucos
barrier
howev
find
remain
explain
possibl
signific
differ
exist
iga
human
speci
addit
well
demonstr
denatur
conform
alter
deglycosyl
chemic
modifi
iga
activ
acp
whether
equival
chang
occur
iga
due
abnorm
synthesi
even
microbi
attack
therebi
initi
activ
complement
consequ
patholog
lesion
interest
specul
support
notion
howev
might
found
iga
nephropathi
propos
defect
glycosyl
lead
deposit
renal
glomeruli
activ
acp
see
chapter
fig
sever
earli
studi
mostli
use
myeloma
iga
protein
colostr
siga
indic
iga
inhibitori
phagocytosi
bactericid
activ
chemotaxi
neutrophil
macrophag
review
kilian
et
al
fig
interact
iga
variou
cell
type
human
cell
myeloid
lineag
neutrophil
eosinophil
monocyt
macrophag
express
activ
serum
iga
especi
polymer
form
aggreg
complex
antigen
bind
siga
least
neutrophil
requir
coreceptor
express
vari
accord
cell
type
state
differenti
activ
locat
signal
transduct
henc
cellular
respons
depend
associ
chain
eosinophil
bind
respond
especi
well
siga
sc
natur
receptor
clear
basophil
also
report
degranul
respons
siga
occur
tand
blymphocyt
physiolog
function
remain
uncertain
interact
iga
nk
cell
mighti
mediat
lectinlik
receptor
carbohydr
determin
dc
variabl
express
anoth
receptor
iga
respons
iga
controversi
epitheli
cell
includ
hepatocyt
certain
nonprim
anim
speci
express
pigr
bind
piga
therebi
transport
apic
surfac
releas
siga
antigen
complex
piga
antibodi
similarli
transport
hepatocyt
bile
intestin
epitheli
cell
gut
lumen
piga
antibodi
might
also
abl
interfer
intracellular
viral
replic
inhibit
respons
lp
within
epitheli
cell
enterocyt
mcell
also
report
bind
iga
possibl
lectinlik
receptor
serum
iga
catabol
hepatocyt
probabl
uptak
mediat
asialoglycoprotein
receptor
detail
see
text
reproduc
permiss
russel
kilian
elsevi
inc
howev
known
receptor
fc
iga
express
myeloid
cell
mediat
phagocytosi
cellular
respons
complex
iga
review
monteiro
van
de
winkel
see
chapter
level
express
vari
cell
type
activ
state
exampl
upregul
gingiv
exud
neutrophil
fanger
et
al
yuan
et
al
absent
macrophag
isol
gut
mucosa
smith
et
al
sever
activ
agent
phorbol
ester
bacteri
lp
even
iga
well
tumor
necrosi
factor
tnf
interleukin
il
granulocyt
monocytecoloni
stimul
factor
gmcsf
enhanc
surfac
express
neutrophil
wherea
interferon
ifn
transform
growth
factor
tgf
downregul
gessl
et
al
hostoff
et
al
maliszewski
et
al
nikolova
russel
reterink
et
al
weisbart
et
al
shen
et
al
piga
effect
miga
crosslink
stewart
et
al
inde
plasma
miga
concentr
suffici
satur
absenc
crosslink
cell
trigger
associ
common
chain
necessari
signal
transduct
et
al
van
egmond
et
al
express
vari
differ
cell
type
state
activ
differenti
locat
hamr
et
al
absenc
signal
chain
iga
might
taken
recycl
without
induc
inflammatori
respons
launay
et
al
bind
siga
appear
requir
accessori
receptor
van
spriel
et
al
thu
numer
factor
involv
determin
whether
myeloid
cell
respond
iga
remark
mice
lack
homologu
impli
differ
exist
physiolog
function
iga
mice
human
howev
found
substitut
iga
receptor
least
mediat
iga
antibodydepend
protect
mycobacterium
tuberculosi
mous
model
reljic
et
al
sever
studi
report
polyclon
human
serum
iga
monoclon
iga
antibodi
promot
phagocyt
uptak
kill
bacteria
pneumonia
n
meningitidi
human
neutrophil
vitro
janoff
et
al
van
der
pol
et
al
vidarsson
et
al
depend
complement
variabl
experi
precis
role
unclear
nonclass
pathway
complement
receptor
implic
preactiv
neutrophil
diminish
depend
complement
igamedi
protect
infect
shown
vivo
use
transgen
mice
express
human
presum
involv
opsonophagocyt
mechan
hellwig
et
al
van
der
pol
et
al
van
egmond
et
al
contrast
opsonophagocyt
activ
report
iga
could
downregul
inflammatori
respons
lpsstimul
human
monocyt
wolf
et
al
wolf
et
al
provok
renew
interest
concept
iga
antiinflammatori
isotyp
howev
subsequ
studi
reveal
signal
transduct
srcfamili
kinas
similar
pathway
induc
fc
receptor
gull
et
al
human
alveolar
macrophag
piga
siga
downregul
respiratori
burst
induc
lp
inhibit
pathway
enhanc
respons
phorbol
ester
associ
phosphoryl
enhanc
releas
mechan
ouadrhiri
et
al
studi
partit
ligandbound
membran
lipid
raft
recruit
tyrosin
kinas
suggest
tempor
regul
signal
event
associ
iga
bind
lang
et
al
interact
iga
type
granulocyt
ie
eosinophil
basophil
henc
role
defens
parasit
allerg
reaction
deserv
attent
highli
glycosyl
isoform
found
eosinophil
decot
et
al
monteiro
et
al
siga
strongli
stimul
degranul
cell
abughazaleh
et
al
iga
also
mediat
kill
schistosom
eosinophil
dunn
et
al
grezel
et
al
distinct
receptor
siga
sc
describ
eosinophil
lamkhiou
et
al
although
function
signific
remain
uncertain
howev
immunoregulatori
role
suggest
siga
inhibit
secret
induc
eosinophil
woerli
et
al
iga
antibodi
long
ago
shown
inhibit
igemedi
hypersensit
ishizaka
et
al
russelljon
et
al
contrast
recent
find
siga
induc
basophil
degranul
iikura
et
al
suggest
possibl
role
allerg
reaction
presenc
iga
receptor
lymphocyt
somewhat
controversi
despit
sever
earlier
report
iga
bind
tor
bcell
receptor
defin
howev
possibl
receptor
iga
igm
recent
found
human
murin
lymphocyt
account
observ
review
shibuya
honda
transferrin
receptor
also
serv
receptor
bcell
epitheli
cell
moura
et
al
abil
natur
killer
nk
cell
bind
iga
especi
might
carbohydr
depend
komiyama
et
al
mota
et
al
physiolog
signific
cellular
inhibit
result
uncertain
current
remain
unclear
whether
iga
direct
function
effect
lymphocyt
found
human
interstiti
dermal
gingiv
dendrit
cell
dc
well
monocytederiv
dc
vitro
langerhan
cell
geissmann
et
al
trigger
monocytederiv
dc
piga
complex
induc
function
activ
endocytosi
complex
product
suggest
interstiti
dc
might
abl
take
process
igaopson
antigen
pasquier
et
al
convers
heystek
et
al
found
express
greatli
diminish
upon
differenti
monocyt
dc
wherea
monocytederiv
dc
bound
siga
independ
activ
result
author
suggest
immatur
dc
might
serv
modul
immun
respons
sigacomplex
antigen
mucos
surfac
becom
clear
dc
repres
highli
variabl
plastic
type
cell
express
receptor
respons
iga
might
also
highli
variabl
depend
precis
type
dc
locat
state
matur
activ
intestin
dc
protrud
lumen
epitheli
cell
mowat
rimoldi
rescigno
express
iga
receptor
might
specul
intestin
iga
antibodi
influenc
immun
respons
initi
cell
interact
iga
epitheli
cell
fig
polymer
iga
along
igm
interact
mucos
epitheli
cell
express
pigr
basolater
surfac
result
piga
endocytos
transport
apic
releas
lumen
coval
coupl
sc
siga
see
chapter
addit
serv
mechan
produc
siga
process
function
consequ
alreadi
discuss
consid
function
siga
mucos
surfac
find
certain
anim
speci
among
rat
mice
rabbit
pigr
express
hepatocyt
therefor
transport
piga
directli
blood
bile
led
demonstr
piga
antibodi
mediat
elimin
bound
antigen
circul
hepatobiliari
transport
peppard
et
al
socken
et
al
propos
mean
noninflammatori
dispos
complex
microbi
antigen
broken
mammalian
tissu
food
antigen
absorb
intestin
russel
et
al
howev
human
hepatocyt
express
pigr
process
occur
human
tomana
et
al
nevertheless
receptor
asialoglycoprotein
receptor
mediat
uptak
desialyl
glycoprotein
catabol
liver
mestecki
et
al
possibl
also
membran
galactosyltransferas
might
contribut
function
similar
transport
process
smaller
scale
tomana
et
al
portion
desialyl
iga
togeth
bound
antigen
taken
receptor
might
becom
missort
biliari
secretori
pathway
instead
lysosom
degrad
pathway
schiff
et
al
schiff
et
al
one
measur
signific
iga
protect
mucosa
human
might
frequenc
bacteri
pathogen
develop
countermeasur
specif
human
iga
classic
exampl
proteas
express
numer
signific
human
mucos
pathogen
close
relat
nonpathogen
speci
tabl
speci
bacteria
produc
igabind
protein
propos
interfer
function
protect
mechan
exert
iga
antibodi
although
well
understood
molecular
character
proteas
catalyt
mechan
reveal
three
distinct
class
enzym
serin
proteas
haemophilu
neisseria
ureaplasma
metalloproteas
streptococcu
capnocytophaga
cystein
proteas
prevotella
well
sever
differ
genet
origin
tabl
mean
uniqu
enzymat
activ
evolv
independ
mani
five
time
bacteri
phylogeni
yet
proteas
show
effect
cleav
human
specif
one
prolineserin
prolinethreonin
bond
hing
region
yield
fragment
degrad
enzym
miga
piga
siga
form
suscept
cleavag
fragment
retain
antigenbind
activ
mansa
kilian
apart
homolog
protein
anthropoid
ape
cole
hale
qiu
et
al
speci
iga
human
cleav
proteas
investig
role
proteas
virul
factor
hamper
exquisit
specif
preclud
use
convent
anim
model
moreov
mani
bacteria
produc
exclus
human
pathogen
howev
indirect
inferenti
evid
suggest
proteas
contribut
virul
organ
produc
one
hypothet
mechan
concern
three
speci
implic
bacteri
mening
haemophilu
influenza
neisseria
meningitidi
pneumonia
produc
proteas
anticapsular
antibodi
might
occur
primari
infect
children
result
prior
exposur
crossreact
antigen
cleav
proteas
fragment
facilit
instead
prevent
invas
organ
moreov
fragment
block
access
function
intact
antibodi
differ
isotyp
howev
proteas
elicit
inhibitori
antibodi
respons
concomit
induct
anticapsular
antibodi
protect
might
achiev
sever
item
evid
lend
indirect
support
hypothesi
proteas
particularli
h
influenza
lesser
extent
n
meningitidi
show
extens
antigen
variat
permit
escap
antibodymedi
inhibit
lomholt
et
al
fragment
shown
ineffect
inhibit
adher
inhibit
complement
activ
mediat
igg
antibodi
result
bacteriolysi
antigen
hajisheng
et
al
janoff
et
al
jarvi
griffiss
reinholdt
kilian
tyler
cole
addit
adher
pneumonia
epitheli
cell
enhanc
presenc
antibodi
capsular
polysaccharid
cleav
proteas
weiser
et
al
analysi
virul
gene
pneumonia
also
reveal
associ
iga
gene
pathogen
mous
model
even
though
murin
iga
suscept
cleavag
proteas
suggest
possibl
addit
activ
proteas
polissi
et
al
howev
possibl
paralog
iga
gene
involv
observ
associ
immunoglobulin
long
thought
benign
form
antibodi
lack
dramat
function
activ
commonli
associ
isotyp
rel
noninflammatori
natur
undoubtedli
import
mucos
surfac
immun
system
continu
expos
abund
microorgan
pathogen
harmless
well
foreign
macromolecul
iga
antibodi
form
immun
complex
antigen
without
necessarili
elicit
inflammatori
reaction
inflict
collater
damag
host
tissu
brandtzaeg
tolo
see
chapter
yet
becom
clear
iga
mediat
potent
respons
cell
possess
receptor
key
understand
physiolog
role
iga
recognit
heterogen
structur
compris
monomer
polymer
secretori
form
two
subclass
human
possibl
sever
glycoform
moreov
variant
differenti
distribut
two
distinct
compart
system
circul
mucos
secret
produc
differ
tempor
kinet
addit
express
cellular
iga
receptor
subject
regul
siga
probabl
littl
opportun
interact
either
complement
phagocyt
mucos
surfac
leukocyt
quickli
disintegr
hypoton
environ
secret
fulli
function
complement
system
usual
present
howev
mucos
barrier
breach
microorgan
becom
expos
environ
domin
submucos
piga
secret
resid
plasma
cell
well
siga
infiltr
neutrophil
express
capabl
respond
igaopson
organ
therebi
provid
immun
defens
iga
might
also
afford
damagelimit
capabl
regul
inflammatori
respons
connect
noteworthi
inflammatori
bowel
diseas
appear
involv
increas
igg
rel
iga
product
affect
tissu
baklien
et
al
observ
preexist
mucos
antibodi
respons
interfer
use
live
bacteri
viral
vector
deliveri
mucos
vaccin
eg
attridg
et
al
robert
et
al
svennerholm
et
al
suggest
siga
antibodi
might
regul
initi
immun
respons
demonstr
infant
mice
suckl
immun
foster
mother
neonat
antibodi
respons
reoviru
suppress
matern
milk
antibodi
kramer
cebra
like
low
level
mucos
antibodi
elicit
commens
bacteria
prevent
overstimul
immun
system
without
actual
elimin
harmless
organ
desir
host
surviv
shroff
et
al
iga
antibodi
human
leukocyt
antigen
hla
class
report
promot
surviv
kidney
allograft
koka
et
al
mechan
underli
appar
suppress
immun
respons
known
seem
like
work
interact
siga
epitheli
cell
mcell
dc
elucid
observ
